J. Pfeilschifter et al., Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets, EUR J PHARM, 429(1-3), 2001, pp. 279-286
One of the greatest biomedical breakthroughs of the twentieth century was t
he discovery of endothelium-derived relaxing factor and its identification
as nitric oxide (NO). NO has received special attention ever since: besides
its potent vasodilatory and vasoprotective effects, NO was identified as a
key player in innate immunity and was found to act as an unconventional ty
e of neurotransmitter. This article. p focuses on mechanisms of NO signall
ing that form the basis of functional cell responses to accommodate changes
in the cellular microenvironment. Redox-based regulation of signal transdu
ction and, on a more long-term scale, changes in gene expression will be ex
emplified by NO-modulation of matrix components and matrix-metabolizing enz
ymes. It seems to be a safe bet that ongoing analyses of NO signalling and
gene expression will provide a wealth of promising therapeutic targets in h
uman diseases. (C) 2001 Elsevier Science B.V. All rights reserved.